XML 14 R2.htm IDEA: XBRL DOCUMENT v3.24.2.u1Close
Consolidated Statements of Income - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Revenues        
Premiums $ 11,454 $ 11,039 $ 23,057 $ 22,064
Net investment income 321 278 611 555
TOTAL REVENUES 60,523 48,586 117,778 95,103 Close
Benefits and expenses        
Pharmacy and other service costs 44,492 33,442 85,923 64,901
Medical costs and other benefit expenses 9,515 9,034 18,955 18,080
Selling, general and administrative expenses 3,684 3,434 7,389 6,972
Amortization of acquired intangible assets 420 455 843 914
TOTAL BENEFITS AND EXPENSES 58,111 46,365 113,110 90,867 Close
Income from operations 2,412 2,221 4,668 4,236 Close
Interest expense and other (375) (363) (697) (721) Close
Loss on sale of businesses 0 0 (19) 0 Close
Net realized investment (losses) gains (48) 26 (1,884) (30) Close
Total Other Income Expenses -423.0 -337.0 -2600.0 -751.0 0 Close
Income before income taxes 1,989 1,884 2,068 3,485 CloseClose
TOTAL INCOME TAXES 360 374 651 669 Close
Net income 1,629 1,510 1,417 2,816 Close
Less: Net income attributable to noncontrolling interests 81 50 146 89
SHAREHOLDERS’ NET INCOME $ 1,548 $ 1,460 $ 1,271 $ 2,727
Shareholders' net income per share        
Basic (in dollars per share) $ 5.51 $ 4.96 $ 4.48 $ 9.24
Diluted (in dollars per share) $ 5.45 $ 4.92 $ 4.43 $ 9.15
Pharmacy revenues        
Revenues        
Revenue from contract with customer $ 45,101 $ 33,964 $ 87,137 $ 66,108
Fees and other revenues        
Revenues        
Revenue from contract with customer $ 3,647 $ 3,305 $ 6,973 $ 6,376